When was Protillion founded?

Protillion was founded in 2018 and raised its 1st funding round 2 years after it was founded.

Where is Protillion located?

Protillion is headquartered in Burlingame, United States.

Who is the current CEO of Protillion?

Curtis Layton of Protillion. They have also founded 1 company.

How many employees does Protillion have?

As of Aug 31, 2026, the latest employee count at Protillion is 23.

Is Protillion a funded company?

Protillion is a funded company, having raised a total of $19M across 2 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on May 01, 2020.

When was the latest funding round of Protillion?

Protillion's latest funding was a $***** Series A round on Dec 19, 2022, with participation from 2 investors. Its primary sector is Genomics. In United States, the Genomics sector has seen $2.33B in funding in 2026 to date.

Where does Protillion rank among its competitors?

Protillion ranks 8th amongst 127 active competitors, of which 38 are funded. It stands 8th in terms of total funding among its competitors. The most recent competitor to raise funding was Nanopore Technologies, which secured $102M in Aug, 2024.

Who are the top competitors of Protillion?

Protillion's top competitors include Nanopore Technologies, PacBio and Complete Genomics. Among them, Nanopore Technologies secured the most recent funding round in August, 2024.

Protillion - 2026 Company Profile, Team, Funding & Competitors

Company Details

Provider of platform for protein analysis. Biologics (e.g. protein drugs) direct protein analysis techniques lag well behind DNA sequencing methods in throughput and automation, making the identification of new protein drug candidates.

Website: protillion.com
Email ID: *****@protillion.com
Phone Number: +1 **********

Key Metrics

Founded Year

2018

Location

Burlingame, United States

Stage

Series A

Total Funding

$19M in 2 rounds

Latest Funding Round

Series A, Dec 19, 2022, $*****

Investors

Arch Venture Partners & 2 more

Ranked

8^th among 127 active competitors

Employee Count

23 as on Aug 31, 2026

Similar Companies

Nanopore Technologies & 157 more

View Protillion's full profile

Protillion has raised a total funding of $19M over 2 rounds. Its first funding round was on May 01, 2020. Its latest funding round was a Series A round on Dec 19, 2022 for $*****. 2 investors participated in its latest round. Protillion has 3 institutional investors.

Here is the list of recent funding rounds of Protillion:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Dec 19, 2022	3052123	Series A	1346445	5916751	6698419	5440507
May 01, 2020	6838207	Grant (prize money)	4585033	6001387	2602493	HHS

Access funding benchmarks and valuations. Sign up today!

View details of Protillion's funding rounds and investors

The founders of Protillion is Curtis Layton. Curtis Layton is the CEO of Protillion.

Here are the details of Protillion's key team members:

Curtis Layton: Founder & CEO of Protillion.
Contact Info: 2 email addresses

View details of Protillion's Founder profiles and Board Members

Protillion's employee count trend

Protillion has 23 employees as of Aug 26. Here is Protillion's employee count trend over the years:

Uncover Protillion's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Protillion include Nanopore Technologies, PacBio and Complete Genomics. Here is the list of Top 10 competitors of Protillion, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Nanopore Technologies 2005, Oxford (United Kingdom), Public	Manufacturer of portable and benchtop devices for real-time DNA sequencing	$1.34B	IP Group, GIC & 94 others	75/100
2nd	PacBio 2004, Menlo Park (United States), Public	Developer of instrument systems and software for real-time sequencing of single-molecules	$410M	Deerfield, Kleiner Perkins & 24 others	72/100
3rd	Complete Genomics 2006, San Jose (United States), Acquired	Developer of DNA sequencing platform for human genome sequencing and analysis	$125M	Enterprise Partners Venture Capital, Orbimed ... & 8 others	66/100
4th	Ultima Genomics 2016, Newark (United States), Series D	Developer of high-throughput NGS instrument for research	$600M	General Atlantic, Lightspeed Venture Partners ... & 8 others	63/100
5th	Singular Genomics 2016, San Diego (United States), Acquired	Provider of next-generation gene sequencing and multi-omics technologies	-	Perceptive Advisors, Domain Associates & 5 others	62/100
6th	Bionano 2002, San Diego (United States), Public	Provider of genome analysis solutions to researchers and clinicians	$124M	Battelle Ventures, Domain Associates & 17 others	58/100
7th	Bioskryb 2018, Durham (United States), Seed	Developer of a genome sequencing and amplification system	$11.5M	Anzu Partners, Wilson Sonsini Goodrich & Rosati	55/100
8th	Protillion 2018, Burlingame (United States), Series A	Provider of platform for protein analysis	$19M	Illumina Ventures, Arch Venture Partners & 1 others	53/100
9th	Omniome 2013, San Diego (United States), Acquired	Provider of genome sequencing platform	$160M	Decheng Capital, Hillhouse & 12 others	52/100
10th	ReadCoor 2016, Cambridge (United States), Acquired	Innovating single-cell, spatial, and in situ biology tools for researchers	$55.6M	Decheng Capital, Pavilion Capital Partners ... & 6 others	51/100